Skip to content

Clinical trials

Phase 2 Diabetes Complications trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Complications Phase: Phase 2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20121
20152
20171
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated6
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
University of Colorado, Denver2
AbbVie1
Allergan1
Beth Israel Deaconess Medical Center1
Goldfinch Bio, Inc.1
Lakewood-Amedex Inc1
Motus Therapeutics, Inc.1
Quark Pharmaceuticals1
The Institute for Diabetes Discovery, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Complications13
Diabetes Mellitus8
Diabetic Nephropathies4
Diabetic Foot3
Diabetic Neuropathies3
Endocrine System Diseases3
Foot Ulcer3
Gastroparesis2
Kidney Diseases2
Urologic Diseases2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.